Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol and Clobazam Interaction Study (OLE)
NCT02564952Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol in epilepsy, sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Number Of Participants Who Experienced Severe OLE-Emergent Adverse Events. Started Mar 2016; status: completed.
02
Drugs
cannabidiol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02564952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564952.